Future of the Genome Sequencing Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Genome Sequencing Market Size Growth Forecast: What to Expect by 2025?
The rapid expansion of the genome sequencing market has been witnessed in the past few years. The market, valued at $9.89 billion in 2024, is projected to increase to $11.78 billion in 2025, with a compound annual growth rate (CAGR) of 19.1%. Factors contributing to this growth during the historical period include enhanced research funding, increasing consciousness about personalized medicine, a surge in genomic data, growth in clinical applications, and heightened demand for biomarker discovery.

How Will the Genome Sequencing Market Size Evolve and Grow by 2029?
The market size for genome sequencing is set to experience robust expansion in the coming years. It is projected to reach $23.63 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 19.0%. This surge over the forecast period can be credited to the expansion of genomic research, the mounting prevalence of genetic disorders, escalating instances of cancer, the incorporation of other omics, and increased public enlightenment and acceptance. Notable developments expected during the forecast period encompass advancements in Next-Generation Sequencing (NGS) technologies, incorporation of Artificial Intelligence (AI) and Machine Learning (ML), the proliferation of Direct-to-Consumer (DTC) genetic testing, the advent of compact sequencing devices, and the emergence of personalized medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genome-sequencing-global-market-report

What Drivers Are Propelling the Growth of Genome Sequencing Market Forward?
The growing prevalence of cancer is anticipated to drive the expansion of the genome sequencing market. Cancer comprises a series of diseases marked by the rampant growth and dissemination of irregular cells, which can be fatal if not restrained. Several elements, including an aging populace, lifestyle dynamics, environmental exposures, and genetic susceptibilities, are contributing to the hike in cancer incidence. Genome sequencing plays an instrumental role in detecting genetic abnormalities and susceptibilities to cancer, facilitating early diagnosis and personalized treatment strategies. It uncovers inherited cancer threats and aids in monitoring the progression of malignant cells. For example, per the World Health Organization, an intergovernmental organization based in Switzerland, new cancer cases are forecasted to exceed 35 million by 2050, signifying a 77% spike compared to 20 million cases in 2022 in February 2024. Therefore, the rising prevalence of cancer is serving as a catalyst for the genome sequencing market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19484&type=smp

Which Emerging Trends Are Transforming the Genome Sequencing Market in 2025?
Prominent corporations within the genome sequencing market are concentrating on devising innovative solutions such as assays based on next-generation sequencing (NGS) to increase precision in genetic analysis and foster personalized medicine methods. These NGS-based assays are sophisticated genomic technologies which expedite and amplify the sequencing of DNA or RNA, aiding in the exploration of genetic matter. Being capable of sequencing a multitude of DNA or RNA fragments simultaneously, NGS generates a substantial amount of data swiftly and more economically. For instance, in April 2023, a genetic diagnostics service for rare conditions called Centogene N.V based in Germany, introduced CentoGenome, an advanced assay based on Next Generation Sequencing (NGS). It provides ongoing diagnostic aid with the confirmation of proactive diagnosis and reclassification plans at zero added expense, which assures consistent patient care and precise disease regulation. Using a PCR-free method, CentoGenome decreases bias and escalates sequencing quality, which offers improved coverage of intricate genomic regions and augments understanding into coding, regulatory, and intronic regions. The platform includes an automated bioinformatics pipeline and professional medical scrutiny, leveraging CENTOGENE's large bio databank consisting of data from approximately 700,000 patients across more than 120 countries. This extensive dataset enhances the identification of disease-causing variants, including those related to spinal muscular atrophy and Parkinson's disease.

What Are the Key Segments in the Genome Sequencing Market?
The genome sequencingmarket covered in this report is segmented -

1) By Product: Consumables, Systems And Software, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction, Purification, Other Technologies
3) By Applications: Diagnostics, Drug Discovery, Precision Medicine, Environmental Genomics, Research, Other Applications
4) By End-User: Hospitals And Clinics, Biotechnology And Pharmaceutical Companies, Contract Research Organizations (CROs), Government, Research Centers, Academic And Government Institutes, Other End-Users

Subsegments:
1) By Consumables: Reagents And Kits, Sequencing Chips And Plates, Sample Preparation Products, Library Preparation Kits, DNA And RNA Extraction Kits
2) By Systems And Software: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Bioinformatics Software And Analysis Tools, Data Management And Storage Solutions, Laboratory Information Management Systems (LIMS)
3) By Services: Sequencing Services, Bioinformatics Analysis Services, Consultation And Support Services, Custom Genome Sequencing Solutions, Sample Collection And Preparation Services.

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19484&type=smp

Who Are the Key Players Shaping the Genome Sequencing Market's Competitive Landscape?
Major companies operating in the genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton, inson and Company, Eurofins Genomics, Agilent Technologies Inc., PerkinElmer, Illumina Inc., bioMérieux, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Group, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., LI-COR Inc., CENTOGENE N.V., Bioneer Corporation, Strand Life Sciences Pvt Ltd., Nebula Genomics

What Geographic Markets Are Powering Growth in the Genome Sequencing Market?
North America was the largest region in the genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19484

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.